Current Vascular Pharmacology
Title: Editorial [Hot topic: An Update on Venous Thromboembolism in Trauma, Orthopaedic and Reconstructive Surgery (Guest Editors: Peter V. Giannoudis and Panayotis N. Soucacos)]
Volume: 9 Issue: 1
Author(s): Peter V. Giannoudis and Panayotis N. Soucacos
Affiliation:
Export Options
About this article
Cite this article as:
V. Giannoudis Peter and N. Soucacos Panayotis, Editorial [Hot topic: An Update on Venous Thromboembolism in Trauma, Orthopaedic and Reconstructive Surgery (Guest Editors: Peter V. Giannoudis and Panayotis N. Soucacos)], Current Vascular Pharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157016111793744733
DOI https://dx.doi.org/10.2174/157016111793744733 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Direct Thrombin Inhibitors for Treatment of Heparin Induced Thrombocytopenia, Deep Vein Thrombosis and Atrial Fibrillation
Current Pharmaceutical Design Deep Vein Thrombosis and Pulmonary Embolism in the Apixaban Era: From Bench to Bedside
Current Drug Targets Clinical Characteristics of Inpatients with Coronavirus Disease 2019 and Acute Ischemic Stroke: From Epidemiology to Outcomes
Current Neurovascular Research Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Correlations Between Carotid IMT, Factor VIII Activity Level and Metabolic Disturbances: A Cardio-Vascular Risk Factor in the HIV Positive Persons
Current HIV Research Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach
Current Pharmaceutical Design Markers of Arrhythmogenic Risk in Hypertensive Subjects
Current Pharmaceutical Design Fibrinolytic Actinokinase-A Short Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Potential Advantages of Using Synchrotron X-ray Based Techniques in Pediatric Research
Current Medicinal Chemistry Thrombolytic Treatment of Cardiac Myxoma-Induced Ischemic Stroke: A Review
Current Drug Safety New Anticoagulants for Prevention and Treatment of Venous Thromboembolism
Current Vascular Pharmacology The Use of Novel Oral Anticoagulants in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets Direct Antithrombins: New Perspectives in Cardiovascular Medicine
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Therapy Against Reperfusion-induced Microvascular Injury
Current Pharmaceutical Design Thromboembolism with Immunomodulatory Agents in the Treatment of Multiple Myeloma
Cardiovascular & Hematological Agents in Medicinal Chemistry Hematoma Expansion: Clinical and Molecular Predictors and Corresponding Pharmacological Treatment
Current Drug Targets Metallocarboxypeptidases and their Inhibitors: Recent Developments in Biomedically Relevant Protein and Organic Ligands
Current Medicinal Chemistry Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation
Current Cardiology Reviews Treatment Related Morbidity in Cervical Cancer
Current Women`s Health Reviews Anticoagulant and Fibrinolytic Drugs – Possible Agents in Treatment of Lung Cancer?
Anti-Cancer Agents in Medicinal Chemistry